Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Louis Excler

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
AIDS Research and Human Retroviruses|December 1, 2009
A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteersVadakkuppatu Devasenapathi Ramanathan, Makesh Kumar, Jayashri Mahalingam, et al.
Journal of the National Cancer Institute. Monographs|November 12, 2024
Community intervention of a single-dose or 2-dose regimen of bivalent human papillomavirus vaccine in schoolgirls in Thailand: vaccine effectiveness 2 years and 4 years after vaccinationSuchada Jiamsiri, Chulwoo Rhee, Hyeon Seon Ahn, et al.
Journal of the International AIDS Society|January 3, 2019
Molecular epidemiology of a primarily MSM acute HIV-1 cohort in Bangkok, Thailand and connections within networks of transmission in AsiaDavid Chang, Eric Sanders-Buell, Meera Bose, et al.
AIDS Research and Human Retroviruses|August 4, 2015
IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine RegimensNicos Karasavvas, Chitraporn Karnasuta, Hathairat Savadsuk, et al.
Vaccine|May 20, 2018
Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and childrenMaria Rosario Capeding, Samuel Teshome, Tarun Saluja, et al.
Plos One|August 8, 2012
A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adultsMichael C Keefer, Jill Gilmour, Peter Hayes, et al.
The Journal of Infectious Diseases|January 13, 2017
First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost RegimensJulien Nyombayire, Omu Anzala, Brian Gazzard, et al.
Eclinicalmedicine|November 5, 2020
Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind StudyMaria Rosario Capeding, Arijit Sil, Birkneh Tilahun Tadesse, et al.
The Lancet. Infectious Diseases|March 19, 2018
Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trialFirdausi Qadri, Mohammad Ali, Julia Lynch, et al.
The Lancet. HIV|February 10, 2020
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trialPunnee Pitisuttithum, Sorachai Nitayaphan, Suwat Chariyalertsak, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
AIDS Research and Human Retroviruses|December 1, 2009
A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteersVadakkuppatu Devasenapathi Ramanathan, Makesh Kumar, Jayashri Mahalingam, et al.
Journal of the National Cancer Institute. Monographs|November 12, 2024
Community intervention of a single-dose or 2-dose regimen of bivalent human papillomavirus vaccine in schoolgirls in Thailand: vaccine effectiveness 2 years and 4 years after vaccinationSuchada Jiamsiri, Chulwoo Rhee, Hyeon Seon Ahn, et al.
Journal of the International AIDS Society|January 3, 2019
Molecular epidemiology of a primarily MSM acute HIV-1 cohort in Bangkok, Thailand and connections within networks of transmission in AsiaDavid Chang, Eric Sanders-Buell, Meera Bose, et al.
AIDS Research and Human Retroviruses|August 4, 2015
IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine RegimensNicos Karasavvas, Chitraporn Karnasuta, Hathairat Savadsuk, et al.
Vaccine|May 20, 2018
Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and childrenMaria Rosario Capeding, Samuel Teshome, Tarun Saluja, et al.
Plos One|August 8, 2012
A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adultsMichael C Keefer, Jill Gilmour, Peter Hayes, et al.
The Journal of Infectious Diseases|January 13, 2017
First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost RegimensJulien Nyombayire, Omu Anzala, Brian Gazzard, et al.
Eclinicalmedicine|November 5, 2020
Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind StudyMaria Rosario Capeding, Arijit Sil, Birkneh Tilahun Tadesse, et al.
The Lancet. Infectious Diseases|March 19, 2018
Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trialFirdausi Qadri, Mohammad Ali, Julia Lynch, et al.
The Lancet. HIV|February 10, 2020
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trialPunnee Pitisuttithum, Sorachai Nitayaphan, Suwat Chariyalertsak, et al.
Pageof 12